1. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI). (1986). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet, 1, 871–874.
2. ISIS-2 (second International Study of Infarct Survival) Collaborative Group. (1988). Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, 2, 349–360.
3. ISAM Study Group. (1986). A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). N. Engl. J. Med., 314, 1465–1471.
4. AIMS Trial Study Group. (1988). Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial. Lancet, 1, 545–549.
5. Wilcox, R.G. et al. (1988). Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis ( ASSET ). Lancet, 2, 525–530.